Invesaro

Stocks PCTY Financial statements

Financial statements

Paylocity Holding Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Paylocity Holding Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue3003784685616368531,1751,4031,5951,771
Cost of revenue124149154182219287367442498546
Gross profit1762283143794165668089611,0971,226
Research and development29.137.650.362.876.7103164178206221
Selling and marketing77.595.5113145162214297335374394
General and administrative62.179.394.6105120164192187213224
Operating expenses169212258313358481653701793840
Operating income7.315.956.266.25884.6155260304386
Other non-operating income0.070.81.820.95-0.94-13.5916.95.041.31
Pre-tax income7.3716.85867.157.183.6159277309387
Income tax0.65-21.84.222.66-13.7-7.1817.870.281.9118
Net income6.7238.653.864.570.890.8141207227270
EBITDA28.346.290.8104101135216337404498
EPS, basic0.130.741.021.201.301.652.533.684.084.99
EPS, diluted0.120.700.971.151.261.612.493.634.024.92
Shares, basic (weighted)51.452.452.953.554.35555.756.255.654.1
Shares, diluted (weighted)54.154.955.455.856.356.456.65756.654.8

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents103137132251202140289402398272
Short-term investments0.7329.334.64.460
Receivables2.043.454.364.926.2715.825.13341.650.1
Other current assets14.911.213.913.21628.935.139.850.957.6
Total current assets1,0631,3781,5961,6632,0334,2323,0483,5243,3123,723
Property, plant and equipment40.86270.166.759.862.864.160.654.271.4
Lease right-of-use assets48.74449.244.133.83633.1
Goodwill69.599.5921.733.7102102109343379
Intangible assets8.911310.813.41345.534.528.392.786.1
Total assets1,1371,5081,8041,9862,4154,8093,6964,2454,3894,884
Accounts payable2.052.993.951.764.238.376.158.6417.310.9
Accrued liabilities30.342.257.679.9103124143158193200
Deferred revenue0.655.578.789.4413.524.525.935.742.6
Total current liabilities9751,2711,4561,4091,8674,1212,7753,1172,9053,420
Lease liabilities73.367.269.162.546.846.842.2
Other non-current liabilities1.121.721.751.963.683.736.48.5812.9
Total liabilities9901,2951,4961,5931,9384,1962,8533,2123,1563,663
Total debt100016381.3
Paid-in capital19322020822824229038136032852.3
Retained earnings-45.3-6.6899.81642353264676739011,170
Other comprehensive income-0.140.110.680.07-2.3-4.52-0.945.59-1.23
Shareholders' equity1482133083934776138431,0331,2341,221
Total equity1482133083934776138431,0331,2341,221
Total liabilities and equity1,1371,5081,8041,9862,4154,8093,6964,2454,3894,884
Shares outstanding51.752.853.153.854.655.255.955.555.453.3

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income6.7238.653.864.570.890.8141207227270
Depreciation and amortization2130.234.637.94350.260.976.499.6112
Stock-based compensation26.730.438.847.563.196.2147146143139
Deferred income tax0.15-21.94.132.75-13.6-7.1813.527.8-3.2182.9
Change in receivables-0.47-1.49-1.19-0.73-1.65-7.61-9.41-8.19-3.56-7.93
Cash from operations6297.9115113125155283385418533
Capital expenditures-21.3-21.7-11.3-16.6-9.46-18.1-21.9-18-13.1-36.2
Acquisitions-6.66-16.7-15-1080-12-278-49.2
Purchases of investments-197-251-4000-434-599-304-261-271
Cash from investing-37.8-179-43.3-48.848.4-480-220-102-456-155
Stock issued0.030.0900.1500
Share buybacks-3500-150-150-398
Cash from financing-3042751152.092802,172-1,435142-3268.98
Net change in cash-280194186664541,848-1,372424-363387
Free cash flow40.676.210496.1115137261367405497
Interest paid0.440.870.310.40.4912.85.57
Income taxes paid0.03-0.050.410.08-0.140.011.3647.686.133.2

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $143.35 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin69.2%Gross profit / revenue.
Operating margin21.8%Operating income / revenue.
EBITDA margin28.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin21.9%Pre-tax income / revenue.
Net margin15.2%Net income / revenue.
FCF margin28.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin30.1%Cash from operations / revenue.
Effective tax rate30.4%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)22.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.8%Net income / average total assets.
Return on invested capital (ROIC)26.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue12.5%Research and development expense / revenue.
Stock-based pay / revenue7.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.0%Capital expenditures / revenue.
D&A / revenue6.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y11.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y14.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y22.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y11.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y24.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y27.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y35.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y46.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y23.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y32.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y37.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y18.8%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y24.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y30.7%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y22.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y25.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y31.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y27.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y23.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y33.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y22.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y24.0%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y33.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-1.0%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y20.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y9.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y15.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.09xCurrent assets / current liabilities.
Quick ratio0.09x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.08x(Cash + short-term investments) / current liabilities.
Debt / equity0.07xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets1.7%Total debt / total assets.
Liabilities / assets75.0%Total liabilities / total assets.
Net debt-$190.7MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.38xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital$302.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets9.5%(Goodwill + intangible assets) / total assets.
Tangible book value$756.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.38xRevenue / average total assets.
Fixed asset turnover28.2xRevenue / average property, plant and equipment.
Receivables turnover38.6xRevenue / average receivables.
Days sales outstanding9 days365 x average receivables / revenue.
Days payables9 days365 x average accounts payable / cost of revenue.
FCF conversion184.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow6.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$4.92Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$4.99Net income per basic share, as reported (split-adjusted).
Revenue per share$32.34Revenue / diluted weighted shares.
FCF per share$9.08Free cash flow / diluted weighted shares.
Operating cash flow per share$9.74Cash from operations / diluted weighted shares.
Book value per share$22.93Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$14.20Tangible book value / shares outstanding.
Cash per share$5.10(Cash + short-term investments) / shares outstanding.
Buybacks / FCF80.1%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$7.61BShare price x shares outstanding.
Enterprise value$7.42BMarket cap + total debt - cash - short-term investments.
P/E28.2xMarket cap / net income. Only when net income is positive.
P/S4.29xMarket cap / revenue.
P/B6.23xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book10.1xMarket cap / tangible book value, when positive.
P/FCF15.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF14.3xMarket cap / cash from operations, when positive.
EV/Sales4.19xEnterprise value / revenue.
EV/EBIT19.2xEnterprise value / operating income, when both are positive.
EV/EBITDA14.9xEnterprise value / EBITDA, when both are positive.
EV/FCF14.9xEnterprise value / free cash flow, when both are positive.
FCF yield6.5%Free cash flow / market cap.
Earnings yield3.5%Net income / market cap (the inverse of P/E).
Shareholder yield5.2%(Dividends paid + share buybacks) / market cap.
PEG1.11xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Paylocity Holding Corp's revenue in fiscal 2026?

Paylocity Holding Corp reported revenue of $1.77B for fiscal 2026, 11% higher than the year before.

Was Paylocity Holding Corp profitable in fiscal 2026?

Yes. Net income was $269.7M, a net margin of 15.2%.

How much free cash flow did Paylocity Holding Corp generate in fiscal 2026?

Cash from operations of $533.3M minus capital expenditures of $36.2M left free cash flow of $497.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Paylocity Holding Corp